|1.||Park, Sung-Joo: 16 articles (05/2015 - 08/2005)|
|2.||Cuzzocrea, Salvatore: 16 articles (07/2012 - 05/2002)|
|3.||Song, Ho-Joon: 15 articles (05/2015 - 02/2006)|
|4.||Steiner, Jörg M: 15 articles (01/2015 - 09/2003)|
|5.||Mazzon, Emanuela: 13 articles (07/2012 - 05/2002)|
|6.||Di Paola, Rosanna: 13 articles (05/2012 - 09/2003)|
|7.||Tomaszewska, R: 13 articles (10/2010 - 10/2001)|
|8.||Cravatt, Benjamin F: 12 articles (07/2015 - 01/2010)|
|9.||Bae, Gi-Sang: 12 articles (05/2015 - 10/2008)|
|10.||Warzecha, Z: 12 articles (10/2010 - 10/2001)|
09/01/2012 - "As there is currently no gold standard for antemortem diagnosis of pancreatitis in dogs and cats, the combination of a complete history and physical examination, measurement of pancreatic lipase immunoreactivity, and ultrasonographic examination of the pancreas is the best approach for an accurate noninvasive diagnosis of pancreatitis."
11/01/1981 - "The results of this study also showed that low serum lipase values almost always eliminated the possibility of pancreatitis and that high values were often, but not always, diagnostic for pancreatitis."
04/01/1984 - "The turbidimetric test was helpful for rapid quantitative determination of serum lipase and thus for the early and accurate diagnosis of acute pancreatitis."
05/01/2014 - "Development of a feline-specific pancreatic lipase immunoassay has improved our diagnostic ability in the past decade, but may have more limited application for mild and chronic forms of pancreatitis. "
08/01/2015 - "Serum lipase is now the preferred test due to its improved sensitivity, particularly in alcohol-induced pancreatitis. "
|2.||Body Weight (Weight, Body)
07/01/2015 - "Whereas, the administration of CA to HFD-fed rats improved the body weight gain and serum lipid profile and reverted back near to normal the activities of lipase and ACE. "
12/01/2015 - "This study aims to evaluate for the first time the effects of Cymodocea nodosa sulphated polysaccharide (CNSP) on lipase activity in vitro and in vivo to high fat diet (HFD)-rats on body weight, lipid profile and liver-kidney functions. "
11/12/2009 - "Taken together, the results of the present study suggest that long-term, daily administration of PF-W successfully suppressed body weight gain-apparently due to accelerated intestinal transit and not to interference with pancreatic lipase activity. "
11/12/2009 - "PF-W was used in following experiments: 10-week-long measurement of body weight and food intake, in vitro pancreatic lipase activity assay, in vivo triglyceride concentration study, and measurement of intestinal transit rate. "
12/01/2015 - "The administration of CNSP decreases the body weight and inhibits lipase activity of obese rats in serum and intestine as compared with untreated HDF-rats. "
05/01/2012 - "Previous studies demonstrated that loss-of-function mutations of Lmf1 result in diminished lipase activity and severe hypertriglyceridemia in mice and human subjects. "
06/01/2010 - "Recent studies identified mutations in LMF1 that cause combined lipase deficiency and hypertriglyceridemia in humans. "
03/01/2015 - "Refeeding intolerance occurs in 12.4% patients with mild AP and appears more often in those with hypertriglyceridemia-induced AP, elevated serum lipase (>2-fold of the upper limit of normal) before refeeding, and immediate feeding."
03/01/2015 - "In the final regression model, hypertriglyceridemia-induced AP (odds ratio, 7.72; 95% CI: 2.50-23.82, P < 0.001), elevated serum lipase (>2-fold of the upper limit of normal) before refeeding (odds ratio, 2.13; 95% CI: 1.2-3.77, P = 0.009), and immediate feeding (odds ratio, 1.75; 95% CI: 1.31-2.33, P < 0.001) were critical risk factors of refeeding intolerance. "
03/01/2015 - "Further investigation revealed severe hypertriglyceridemia (4,009 mg/dL) and elevated lipase (1,714 U/L). "
02/15/2013 - "Inhibition of pancreatic lipase is effective for a prevention of obesity. "
01/01/2014 - "Along with HTS based screening, detailed structure-activity relationship studies on semi-synthetic and synthetic derivatives might also provide a direction for the development of potential lead(s) or pharmacophore for pancreatic lipase inhibition in order to treat and/or prevent obesity and related disorders. "
08/09/2010 - "This study evaluated anti-obesity effect of the ethanolic extract of Morus bombycis root on lipase activity and lipolysis in adipocytes and adipose tissues. "
01/01/2008 - "In this study the inhibitory activities of dandelion (Taraxacum officinale) against pancreatic lipase in vitro and in vivo were measured to determine its possible use as a natural anti-obesity agent. "
10/01/2001 - "Based on the inhibitory effects of teasaponin on pancreatic lipase activity in vitro, this study was performed to clarify whether teasaponin prevented obesity induced in mice by a high-fat diet for 11 weeks. "
|5.||Cystic Fibrosis (Mucoviscidosis)
08/01/2004 - "Among indirect tests, faecal elastase-1 test is superior to faecal lipase test in the assessment of exocrine pancreatic function in cystic fibrosis."
08/01/2004 - "Faecal elastase-1 test is superior to faecal lipase test in the assessment of exocrine pancreatic function in cystic fibrosis."
01/01/1992 - "Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhoea due to cystic fibrosis."
04/01/1998 - "The study evaluates faecal immunoreactive lipase (IRL) measurement in spot stool samples as an index of exocrine pancreatic function in patients with cystic fibrosis (CF). "
05/28/1983 - "A study was undertaken to discover whether activity of pancreatic lipase is also altered in cystic fibrosis. "
|2.||Lipoprotein Lipase (Diacylglycerol Lipase)
|8.||Proteins (Proteins, Gene)
|2.||Total Parenteral Nutrition
|4.||Fat-Restricted Diet (Diet, Fat Restricted)